Kaufman, JL, Usmani, SZ, San-Miguel, J et al. (16 more authors) (2020) Four-Year Follow-up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Relapsed or Refractory Multiple Myeloma (RRMM). In: 61st American Society of Hematology (ASH) Annual Meeting, 07-10 Dec 2019, Orlando, Florida, USA.
Metadata
Authors/Creators: |
|
---|---|
Dates: |
|
Institution: | The University of Leeds |
Depositing User: | Symplectic Publications |
Date Deposited: | 27 Nov 2020 14:14 |
Last Modified: | 27 Nov 2020 14:14 |
Status: | Published |
Identification Number: | https://doi.org/10.1182/blood-2019-123483 |
Related URLs: |
Download not available
A full text copy of this item is not currently available from White Rose Research Online